Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
Aadhavi SridharanMartin S MaronRichard T CarrickChristopher A MadiasDou HuangCraig CooperJennifer DrummondBarry J MaronEthan J RowinPublished in: Journal of cardiovascular electrophysiology (2021)
In adult HCM patients comorbidities do not appear to impact AF or SCD risk. Therefore, for most patients with HCM, adverse disease related events of AF and SCD appear to be primarily driven by underlying left ventricular and atrial myopathy as opposed to comorbidities.
Keyphrases
- hypertrophic cardiomyopathy
- atrial fibrillation
- left ventricular
- left atrial
- heart failure
- catheter ablation
- end stage renal disease
- oral anticoagulants
- mitral valve
- ejection fraction
- acute myocardial infarction
- direct oral anticoagulants
- newly diagnosed
- cardiac resynchronization therapy
- percutaneous coronary intervention
- left atrial appendage
- peritoneal dialysis
- aortic stenosis
- prognostic factors
- late onset
- coronary artery disease
- aortic valve